Sign Out
Hypersensitivity to triptorelin, GnRH, luteinizing hormone releasing hormone (LHRH), GnRH agonist analogs, or any component in the product.
Pregnant or breastfeeding women (see Use in Pregnancy & Lactation).
Women with undiagnosed abnormal vaginal bleeding.
Patients with spinal cord compression secondary to prostate cancer metastases.
In the pre-menopausal breast cancer setting: Initiation of aromatase inhibitor before adequate ovarian suppression with triptorelin has been achieved.
